The treatment of tuberculosis in childhood

South African Medical Journal

Volumn 97, Issue 10 II, 2007, Pages 992-994

  Donald, Peter R ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOSALICYLIC ACID; ANTIRETROVIRUS AGENT; CAPREOMYCIN; CARBAMAZEPINE; CORTICOSTEROID; CYCLOSERINE; DIGITALIS; ETHAMBUTOL; ETHIONAMIDE; GATIFLOXACIN; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; ORAL ANTIDIABETIC AGENT; PHENYTOIN; PROTIONAMIDE; PYRAZINAMIDE; PYRIDOXINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TERIZIDONE; TUBERCULOSTATIC AGENT; VIOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBACTERIAL ACTIVITY; ARTHRALGIA; ARTHRITIS; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL PROTOCOL; COLOR VISION; DRUG BLOOD LEVEL; DRUG HYPERSENSITIVITY; DRUG RESPONSE; EXFOLIATIVE DERMATITIS; FLU LIKE SYNDROME; FLUSHING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERURICEMIA; LIVER TOXICITY; MAXIMUM PERMISSIBLE DOSE; MULTIDRUG RESISTANCE; MYCOBACTERIUM; OPTIC NEURITIS; PERCEPTION DEAFNESS; PERIPHERAL NEUROPATHY; PSYCHOSIS; SHORT COURSE THERAPY; SIDE EFFECT; THROMBOCYTOPENIA; TUBERCULOSIS; VISUAL ACUITY;

ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; DRUG ADMINISTRATION SCHEDULE; HUMANS; TUBERCULOSIS;

EID: 35648977115     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979; 76: suppl 6, 771-781.
2. Donald PR, Sirgel FA, Venter A, et al. Early bactericidal activity of antituberculosis agents. Expert Rev Anti-infect Ther 2003; 1: 141-155.
3. World Health Organization. Treatment of Tuberculosis. Guidelines for National Programmes Geneva: WHO, 2003. WHO/CDS/2003.313.
4. Johnson JL, Hadad DJ, Boom WH, et al. Early and extended bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2006, 10: 605-612.
5. Schaaf HS, Drug-resistant tuberculosis in child. S Afr Med J 2007, 97: 995-997 (this issue).
6. Reis FJC, Bedran MBM, Mourn JAR, Assis I, Rodrigues MESM. Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children. Am Rev Respir Dis 1990; 142: 996-999.
7. Al-Dossary FS, Ong LT, Pa-C, Correa AG, Starke JR. Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy. Pediatr Infect Dis J 2002; 21: 91-97.
8. El-Sadr WM, Perlman DC, Denning E, Matts JP, Cohn DL. A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. Clin Infect Dis 2001; 32: 623-632.
9. Driver CR, Munsiff SS, Li J, Kundamal N, Osahan SS. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City. Clin Infect Dis 2001; 33: 1762-1769.
10. Schaaf HS, Parkin DP, Seifart HI, et al. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch Dis Child 2005; 90: 614-618.
11. Donald PR, Maher D, Maritz JS, Qazi S. Ethambutol dosage for the treatment of children: literature review and recommendatiions. Int J Tuberc Lung Dis 2006; 10: 1318-1330.
12. World Health Organization. Guidance for National Programmes on the Management of Tuberculosis in Children. Geneva: WHO, 2006 (WHO/HTM/ TB/2006.371).
13. Donald PR, Schoeman JF, Van Zyl LE, De Villiers JN, Pretorius M, Springer P. Intensive short course chemotherapy in the management of tuberculous meningitis. Int J Tuberc Lung Dis 1998; 2: 704-711.
14. O'Brien RJ. Scientific blueprint for tuberculosis drug development. Tuberculosis 2001; 81: suppl 1, 1-51.
15. Andries K, Verhasselt F, Guillemont J, et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005; 307: 23-227.
16. Matsumuto M, Hashizume T, Tomishige T, et al. OPC-67683, a nito-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.Plos Med 2006; 3: 2131-2144.